NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

All of this is just moot without reimbursement approvals which ain’t happening in 2026 and unlikely in 2027 as well.

The demand without reimbursement will be insignificant. I’d say about 60-70 patients per year, certainly less than 100 patients per year.

So even the existing 450 to 500 patients capacity is more than sufficient for 2026 and 2027.

Grade C wont be certified for commercial production with Eden/Flaskworks until 2028 anyway. Its going to be a long process involving multiple delays, validations, regulatory inspection, wait period from regulators to get the new NWBO application and site visits in the queue, corrective actions, another inspection, etc. So see you in 2028! ;)

See you in 2028!